Bond Bayris 0% ( XS2665619545 ) in EUR
Issuer | Bayris |
Market price | 100 % ⇌ |
Country | ![]() |
ISIN code |
![]() |
Interest rate | 0% |
Maturity | 07/09/2023 - Bond has expired |
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
Minimal amount | / |
Total amount | / |
Detailed description |
Bayer is a multinational pharmaceutical and life science company with core businesses in pharmaceuticals, consumer health, and agricultural products. A specific debt instrument, identified by its ISIN code XS2665619545, issued by the German multinational conglomerate Bayer AG, successfully reached its maturity on September 7, 2023, and has since been fully redeemed. Bayer AG, a globally significant life sciences company headquartered in Leverkusen, Germany, is a prominent player in the pharmaceuticals, consumer health, and crop science sectors, leveraging its extensive research and development capabilities and global market presence. As a regular participant in capital markets, Bayer issues various types of debt instruments to fund its operations and strategic growth initiatives. This particular bond, denominated in Euros (EUR) and originating from Germany, notably featured a zero-coupon structure, meaning it did not pay periodic interest to bondholders. Investors in such instruments typically acquire them at a discount to their face value, with their yield realized through the difference between the discounted purchase price and the full par value received at redemption. On its designated maturity date, the bond was redeemed at 100% of its face value, ensuring that all outstanding principal was repaid to its holders. This successful redemption marks the completion of Bayer's financial commitment for this specific debt security, confirming its effective removal from the active market. |